The presence of antibodies against PD1/PDL1 can strengthen the ability of tumor-infiltrating lymphocytes to kill cancer cells by counteracting the interference of immune functions caused by PD-L1 on the surfaces of cancer cells [34, 35]. The gene discussed is CD274; the disease is cancer.